Prioritization of Lipid Metabolism Targets for the Diagnosis and Treatment of Cardiovascular Diseases
Background: Cardiovascular diseases (CVD) are a major global health issue strongly associated with altered lipid metabolism. However, lipid metabolism-related pharmacological targets remain limited, leaving the therapeutic challenge of residual lipid-associated cardiovascular risk. The purpose of th...
Saved in:
| Main Authors: | Zhihua Wang, Shuo Chen, Fanshun Zhang, Shamil Akhmedov, Jianping Weng, Suowen Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Association for the Advancement of Science (AAAS)
2025-01-01
|
| Series: | Research |
| Online Access: | https://spj.science.org/doi/10.34133/research.0618 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases
by: Tian Tian, et al.
Published: (2025-01-01) -
Lipid rafts: novel therapeutic targets for metabolic, neurodegenerative, oncological, and cardiovascular diseases
by: Mohamad Warda, et al.
Published: (2025-04-01) -
Risk factors of pan-vascular diseases and their interactions
by: Wei Shulin, et al.
Published: (2024-12-01) -
Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in ApoE–/– mice
by: Meijie Chen, et al.
Published: (2024-12-01) -
ACSS2 and metabolic diseases: from lipid metabolism to therapeutic target
by: Alaa El-Kurjieh, et al.
Published: (2025-02-01)